The 5-Second Trick For cancer research
ArticleOpen Access18 Apr 2024 An oncolytic virus providing tumor-irrelevant bystander T mobile epitopes induces anti-tumor immunity and potentiates cancer immunotherapy Ye and colleagues clearly show that an oncolytic virus that delivers tumor-irrelevant bystander T cell epitopes to tumor cells can exploit the plentiful populace of bystander T cell